- Home
- / Shukra Pharmaceuticals
Shukra Pharmaceuticals
Stock Price
₹67.6
2024-10-29
Market Capitalization
₹108.7 M
2024-10-29
Revenue
₹325.9 M
FY, 2025
Shukra Pharmaceuticals Summary
Company Summary
- Overview
- Shukra Pharmaceuticals is a company that develops and manufacture pharmaceutical products. It offers tablets, liquid injectables, and capsules. The company also provides contract manufacturing services.
- Type
- Public
- Status
- Active
- Founded
- 1993
- Cybersecurity rating
Table of Contents
Shukra Pharmaceuticals Financials
Summary Financials
- Revenue (Q3, 2026)
- ₹391.3M
- Gross profit (Q3, 2026)
- ₹328.2M
- Net income (Q3, 2026)
- ₹203.6M
- Cash (Q2, 2026)
- ₹133.6M
- EBIT (Q3, 2026)
- ₹271.1M
- Enterprise value
- $12.7M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026